(Q34024161)

30 July 2017

title

High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives (English)

1 reference

30 July 2017

0 references

1 reference

1

Sebastien Crouzet

1 reference

30 July 2017

Francois J Murat

2

1 reference

30 July 2017

Gilles Pasticier

3

1 reference

30 July 2017

Philippe Cassier

4

1 reference

30 July 2017

Jean Y Chapelon

5

1 reference

30 July 2017

Albert Gelet

6

1 reference

30 July 2017

publication date

30 September 2010

1 reference

International Journal of Hyperthermia

30 July 2017

published in

1 reference

30 July 2017

volume

26

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

796-803

1 reference

Population aging and cancer: a cross-national concern.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High intensity focused ultrasound: surgery of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

MRI appearance of prostate following transrectal HIFU ablation of localized cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Treatment of localized prostate cancer using high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High-intensity focused ultrasound therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Control of prostate cancer by transrectal HIFU in 227 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

Influence of the docetaxel administration period (neoadjuvant or concomitant) in relation to HIFU treatment on the growth of Dunning tumors: results of a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2010.498803

10.3109/02656736.2010.498803

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference